Assessement of the quality of life of patients followed for lung cancer: about Tunisian series (notice n° 502043)

détails MARC
000 -LEADER
fixed length control field 02801cam a2200229 4500500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250121082938.0
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title fre
042 ## - AUTHENTICATION CODE
Authentication code dc
100 10 - MAIN ENTRY--PERSONAL NAME
Personal name Moussa, Nadia
Relator term author
245 00 - TITLE STATEMENT
Title Assessement of the quality of life of patients followed for lung cancer: about Tunisian series
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Date of publication, distribution, etc. 2021.<br/>
500 ## - GENERAL NOTE
General note 10
520 ## - SUMMARY, ETC.
Summary, etc. Introduction: Lung cancer (LC) has a heavy impact on the quality of life (QQL) of patients both physically and psychologically. Aims: Evaluate the QQL of patients with LC and detect the factors associated with its alteration. Methods: This is a descriptive and cross-sectional study, carried out at the pneumology service of Hedi chaker hospital of Sfax (Tunisia) over period of 6 months from June to December 2018, including 80 patients with non-small cell lung cancer classified stage III and IV. Clinical, paraclinical and therapeutic data were collected from medical files of the patients selected. Overall health and QQL, daily activities, sleep disorders, anxiety-depressive disorders were assessed respectively by the EORTC QLQ C30 questionnaire, Performans status (PS), Insomnia severity index (ISI) and Hospital Anxiety and Depression scale (HADS). Results: The mean of age of the patients was 60 years with a male predominance (95%). LC was classified as stage IV (67%). Thirty-seven percent (37%) of patients had à PS equal to 3 and 20% a PS rated at 4. Certain anxiety was observed in 62% of patients and depression in 9%. Insomnia was noted in 36% of patients which was rated severe (10%) and moderate (15%). QQL was altered in 39 patients (49%). The presence of pain, dyspnea, insomnia and fatigue were factors associated with appearance of anxiety-depressive disorders in our patients (p &lt; 0.0001). A statistically significant association was observed between the presence of fatigue, dyspnea and pain and the onset of insomnia (p &lt; 0.0001). The presence of pain, fatigue, insomnia, constipation, abdominal swelling and diarrhea were factors associated with deterioration of the overall health and QQL of our patients. Conclusion: During the course of LC, the patient’s QQL deteriorates dramatically. It is judicious to pay particular attention to this entity and detect the factors which can influence it in order to be able to act with the aim of its improvement within the framework overall care.
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Ghazel, Mariem
Relator term author
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Badri, Imen
Relator term author
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Msaad, Sameh
Relator term author
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Yengui, Ilhem
Relator term author
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Kammoun, Samy
Relator term author
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Khemakhem, Rim
Relator term author
786 0# - DATA SOURCE ENTRY
Note Revue internationale de soins palliatifs | 35 | 4 | 2021-12-08 | p. 181-188 | 1664-1531
856 41 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://shs.cairn.info/journal-infokara-2021-4-page-181?lang=en&redirect-ssocas=7080">https://shs.cairn.info/journal-infokara-2021-4-page-181?lang=en&redirect-ssocas=7080</a>

Pas d'exemplaire disponible.

PLUDOC

PLUDOC est la plateforme unique et centralisée de gestion des bibliothèques physiques et numériques de Guinée administré par le CEDUST. Elle est la plus grande base de données de ressources documentaires pour les Étudiants, Enseignants chercheurs et Chercheurs de Guinée.

Adresse

627 919 101/664 919 101

25 boulevard du commerce
Kaloum, Conakry, Guinée

Réseaux sociaux

Powered by Netsen Group @ 2025